Sorry, you need to enable JavaScript to visit this website.

About The Study

This study is evaluating how the COVID-19 oral treatment PAXLOVID™ (a combination of nirmatrelvir and ritonavir) is absorbed and used in the body, and if it is tolerable for women who are pregnant. If you have recently been diagnosed with COVID-19, please call 800-887-7002 to see if this study may be right for you.

Who May Participate

Joining a clinical trial is an important and personal decision. Thank you for considering this study.

This study may be an option for women who are 18 to 50 years old and meet the requirements below:

  • Tested positive for COVID-19 within the last 5 days
  • Currently have at least 1 symptom related to COVID-19 in the last 5 days
  • In the 2nd or 3rd trimester of pregnancy (14 weeks to 34 weeks and 6 days)

Note: There are other requirements to participate in this study. A study team member will help determine if this study is right for you.

To connect with a member of the study, call 800-887-7002.